Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Withdrawn 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 1Neoplasms 1Glioblastoma 1Coronary Artery Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Molecular Imaging × Clear all
NCT01957332 2024-11-20

IMPACT-MBC

University Medical Center Groningen

Phase NA Active not recruiting
217 enrolled
Breast

Breast Neoplasms

NCT02249520 2024-08-21

Calibration of MR and PET-MR Imaging Protocols at RIC

Cedars-Sinai Medical Center

Phase NA Withdrawn

Coronary Artery Disease, Neoplasms

NCT01622764 2024-05-06

89Zr-RO5323441 PET Imaging in Glioblastoma

University Medical Center Groningen

Phase 2 Withdrawn
CNS

Glioblastoma

NCT02813226 2021-12-21

MISTER

Ontario Clinical Oncology Group (OCOG)

Phase NA Completed
36 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡